Drugs / Prothipendyl
Prothipendyl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prothipendyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567 ↗ |
| Known as | D-206 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111030 ↗ |
| Known as | Dominal | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111030 ↗ |
| Known as | Prothipendyl hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111030 ↗ |
| Known as | PROTHIPENDYL HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111030 ↗ |
| Known as | Protipendilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111030 ↗ |
| Modality | Small molecule | — CHEMBL2111030 ↗ |